APA

Satoh R., Hagihara K., Matsuura K., Manse Y., Kita A., Kunoh T., Masuko T., Moriyama M., Moriyama H., Tanabe G., Muraoka O. & Sugiura R. (20171116). Identification of ACA-28, a 1'-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells. : Genes to cells : devoted to molecular & cellular mechanisms.

Chicago

Satoh Ryosuke, Hagihara Kanako, Matsuura Kazuki, Manse Yoshiaki, Kita Ayako, Kunoh Tatsuki, Masuko Takashi, Moriyama Mariko, Moriyama Hiroyuki, Tanabe Genzoh, Muraoka Osamu and Sugiura Reiko. 20171116. Identification of ACA-28, a 1'-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells. : Genes to cells : devoted to molecular & cellular mechanisms.

Harvard

Satoh R., Hagihara K., Matsuura K., Manse Y., Kita A., Kunoh T., Masuko T., Moriyama M., Moriyama H., Tanabe G., Muraoka O. and Sugiura R. (20171116). Identification of ACA-28, a 1'-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells. : Genes to cells : devoted to molecular & cellular mechanisms.

MLA

Satoh Ryosuke, Hagihara Kanako, Matsuura Kazuki, Manse Yoshiaki, Kita Ayako, Kunoh Tatsuki, Masuko Takashi, Moriyama Mariko, Moriyama Hiroyuki, Tanabe Genzoh, Muraoka Osamu and Sugiura Reiko. Identification of ACA-28, a 1'-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells. : Genes to cells : devoted to molecular & cellular mechanisms. 20171116.